An underground economy for unapproved slimming drugs is being driven by social media fitness personalities and vendors on communication apps, based on new investigations.
Experimental Drug Gaining Popularity Via Social Media
Retatrutide, which is still in research studies, is being promoted by online personalities for its alleged fat-burning effects. Followers are encouraged to contact these profiles directly for source information, while also obtaining promotional offers.
Active Commerce on Social Networks
Additionally, a robust market exists on messaging services, where communities with thousands of members share “before and after” images, injection guides and claims of next-day UK delivery. Sellers market the drug there before directing buyers to WhatsApp for purchases.
Learning About The Experimental Drug
Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could help patients lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.
Healthcare Professionals Voice Worries
However, physicians and chemists have warned that the sale of what is still an unlicensed drug in the UK is worrisome and could lead to users administering substances of unknown origin.
Some professionals said the popularity for retatrutide could be connected to the rising price of licensed slimming treatments such as Mounjaro.
Legal Status and Enforcement
Selling retatrutide on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.
Some content creators attempt to sidestep the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still violate medicines, marketing, and consumer laws, risking fines, legal action or prison.
Service Response and Content Elimination
According to the social media company, the service has taken down violative material and prohibited related hashtags and query recommendations. The company stated it was committed to maintaining the platform secure and investing in enhancing enforcement strategies.
Digital Trading Activities
Research also discovered groups with up to nine thousand participants selling retatrutide using Telegram's integrated search feature, which functions like a online catalog. Entering “retatrutide” immediately displays channels with numerous of members, populated with photos of weight loss, positive reviews and detailed instructions for preparing or administering at residence.
After moments of entering one group, a seller shared contact information, where most transactions occur. The seller provided an instruction manual and promised delivery within two days. When questioned whether the product was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None asked about weight, medical conditions or previous experience.
Item Information and Pricing
Within these communities, posts display black plastic packages with Royal Mail labels, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”
Customers can select between powder vials, mixed at home with sterile water, or ready-to-use injectors usually sold at £160 for 20 milligrams. When questioned how much time a pen should last, vendors give contradictory responses varying between a few weeks to “depends on your body”.
Service Oversight and Safety Measures
A spokesperson for the messaging service stated it regularly moderated dangerous material on its service including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Cautions
“People are administering materials they cannot confirm. Even if the research behind retatrutide is valid, these online products may not contain what they advertise,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.
A medical professional of Asda Online Doctor linked the increase in interest to recent price rises for approved weight-loss medications such as Mounjaro. “With costs rising, individuals are using social media. But counterfeit injections are extremely dangerous. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she explained.
Her team has already seen individuals harmed by personal administration from unverified suppliers. “We understand the disappointment, but buying from messaging apps or WhatsApp is taking chances with your well-being,” stated the doctor. “These materials could be impure or improperly measured.”
Manufacturer Position
A spokesperson from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this time no one can market [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a Lilly experimental product not yet approved … may subject patients to potentially significant health risks”.
